Cantor Fitzgerald Initiates Coverage On Silence Therapeutics with Overweight Rating
Benzinga Newsdesk 4 months ago
Analyst RatingsNewsInitiation
Cantor Fitzgerald analyst Prakhar Agrawal initiates coverage on Silence Therapeutics (NASDAQ:SLN) with a Overweight rating.
Cantor Fitzgerald analyst Prakhar Agrawal initiates coverage on Silence Therapeutics (NASDAQ:SLN) with a Overweight rating.